Market Place
Sourcing Support
All News #Library
Biotech
Quell Starts CHILL Phase 1/2 Trial for QEL-005-CAR-Treg Therapy
03 Mar 2026 //
GLOBENEWSWIRE
Quell Shows Early Efficacy of CAR-Tregs in Liver Transplant
03 Mar 2026 //
GLOBENEWSWIRE
Quell Halts Transplant Trial To Focus On `Chill Not Kill` Treg
05 Feb 2026 //
FIERCE BIOTECH
Quell Therapeutics To Present Positive QEL-005, CAR-Treg Data
25 Oct 2025 //
GLOBENEWSWIRE
Quell Therapeutics Hits Milestone in CAR-Treg for IBD
10 Jun 2025 //
GLOBENEWSWIRE
AGC Biologics Partners with Quell for Cell Therapy Development
17 May 2025 //
PRESS RELEASE
Quell Achieves Milestone for T1D CAR-Treg Cell Therapy Program
18 Nov 2024 //
GLOBENEWSWIRE
Quell Therapeutics To Present CAR-Treg Data At Congresses
22 Oct 2024 //
GLOBENEWSWIRE
Quell Expands CAR-Treg Therapy Pipeline with eXmoor Partnership
24 Sep 2024 //
GLOBENEWSWIRE
Quell: QEL-001 Treg Platform Potential At ASGCT Meeting
02 May 2024 //
GLOBENEWSWIRE
AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
10 Jun 2023 //
REUTERS
Quell Signs Agreement with AstraZeneca to Develop Treg Cell Therapies
09 Jun 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.